TERAZOSIN Side Effects

5613183-2 | Dizziness, Headache, Hypotension, Hypothermia, Hypotonia, Intentional Overdose, Sinus Bradycardia, Suicide Attempt
on Jan 17, 2008 Male patient from TAIWAN, PROVINCE OF CHINA , 75 years of age, was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), headache (What is headache?), hypotension, hypothermia (What is hypothermia?), hypotonia, intentional overdose, sinus bradycardia, suicide attempt. Terazosin dosage: 60 Df, Oral; 300 Mg, Once/single, Oral. Patient was hospitalized.

5374420-5 | Dizziness
Patient was taking Terazosin (View Usage). Patient had the following side effects: dizziness (What is dizziness?) on Jun 27, 2007 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with benign prostatic hyperplasia and. Terazosin dosage: 4mg Hs Po.

5210463-X | Hypotension
Adverse event was reported on Jan 16, 2007 by a Male patient taking Terazosin (View Usage) (Dosage: 6 Mg At Bedtime) was diagnosed with benign prostatic hyperplasia and. Location: UNITED STATES , 90 years of age, weighting 151.2 lb, After Terazosin was administered, patient had the following side effects: hypotension. Patient was hospitalized.

5093912-X | Dizziness, Hypotension
on Aug 29, 2006 Male patient from UNITED STATES , 67 years of age, weighting 227.1 lb, was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypotension. Terazosin dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.


5093295-5 | Hypotension
on Aug 29, 2006 Male patient from UNITED STATES , 83 years of age, weighting 140.0 lb, was treated with Terazosin (View Usage). Patient had the following side effects: hypotension. Terazosin dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DOCUSATE NA 50 MG/SENNOSIDES (View Docusate Na 50 Mg/sennosides Review and Docusate Na 50 Mg/sennosides Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

4918385-6 | Dizziness
Patient was taking Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: dizziness (What is dizziness?) on Feb 17, 2006 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 123.2 lb, . Terazosin dosage: .

4918293-0 | Hypotension
Adverse event was reported on Feb 17, 2006 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: UNITED STATES , 87 years of age, weighting 173.9 lb, Patient experienced the following unwanted or unexpected effects: hypotension.

4918287-5 | Dizziness
on Feb 17, 2006 Male patient from UNITED STATES , 84 years of age, weighting 140.0 lb, was treated with Terazosin (View Usage). Patient had the following side effects: dizziness (What is dizziness?). Terazosin dosage: .

4907401-3 | Cough, Dizziness, Dyskinesia, Hypotension, Loss Of Consciousness, Urinary Incontinence
on Feb 08, 2006 Male patient from UNITED STATES , 80 years of age, weighting 170.6 lb, was diagnosed with benign prostatic hyperplasia, blood pressure (What is blood pressure?) and was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: cough, dizziness (What is dizziness?), dyskinesia, hypotension, loss of consciousness, urinary incontinence (What is urinary incontinence?). Terazosin dosage: 5 Mg Qhs Po. During the same period patient was treated with METOPROLOL (25 Mg Qpm Po) (View Metoprolol Review and Metoprolol Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), ZOCOR (View Zocor Review and Zocor Label ), CHLORPHENIRAMINE MALEATE (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ). Patient was hospitalized.

4907350-0 | Dizziness
Patient was taking Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?) on Feb 08, 2006 from UNITED STATES Additional patient health information: Male patient , 75 years of age, was diagnosed with benign prostatic hyperplasia, hypertension and. Terazosin dosage: 5 Mg Qhs. During the same period patient was treated with FELODIPINE (5 Mg Qd) (View Felodipine Review and Felodipine Label ), HYDROCHLOROTHIAZIDE (25 Mg Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), TRAMADOL (View Tramadol Review and Tramadol Label ). Patient was hospitalized.

4906179-7 | Syncope
Adverse event was reported on Feb 07, 2006 by a Male patient taking Terazosin (View Usage) (Dosage: 1 Mg Qhs) . Location: UNITED STATES , 66 years of age, weighting 210.1 lb, Patient had the following side effects: syncope. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), HYDROCODONE 7.5/ ACETAMINOPHEN (View Hydrocodone 7.5/ Acetaminophen Review and Hydrocodone 7.5/ Acetaminophen Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ). Patient was hospitalized.

4901853-0 | Dehydration, Dizziness, Fall, Head Injury, Loss Of Consciousness
on Feb 02, 2006 Male patient from UNITED STATES , weighting 180.8 lb, was diagnosed with benign prostatic hyperplasia and was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: dehydration, dizziness (What is dizziness?), fall (What is fall?), head injury, loss of consciousness. Terazosin dosage: 5 Mg At Bedtime Po. During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

4887610-2 | Bradycardia, Dehydration, Incorrect Dose Administered, Syncope
on Jan 19, 2006 Male patient from UNITED STATES , 75 years of age, weighting 160.0 lb, was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, dehydration, incorrect dose administered, syncope. Terazosin dosage: 5 Mg Po Q Hs. Patient was hospitalized.

4883277-8 | Fall, Syncope
Patient was taking Terazosin (View Usage). Patient had the following side effects: fall (What is fall?), syncope on Jan 17, 2006 from UNITED STATES Additional patient health information: Male patient , 78 years of age, weighting 145.9 lb, was diagnosed with benign prostatic hyperplasia, hypertension and. Terazosin dosage: 10mg Hs Po. Patient was hospitalized.

4833984-8 | Urticaria
Adverse event was reported on Nov 18, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: UNITED STATES , 81 years of age, weighting 167.1 lb, After Terazosin was administered, patient had the following side effects: urticaria. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), LORATADINE (View Loratadine Review and Loratadine Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), OXCYCODONE 5 MG/ACETANUBIOGEB (View Oxcycodone 5 Mg/acetanubiogeb Review and Oxcycodone 5 Mg/acetanubiogeb Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

4823025-0 | Hypotension, Overdose
on Nov 07, 2005 Male patient from UNITED STATES , 84 years of age, weighting 185.0 lb, was diagnosed with hypertension and was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, overdose. Terazosin dosage: 10mg Hs Po. During the same period patient was treated with LISINOPRIL (5mg Hs Po) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

4820371-1 | Hypotension
on Nov 02, 2005 Male patient from UNITED STATES , 85 years of age, weighting 173.3 lb, was treated with Terazosin (View Usage). Patient had the following side effects: hypotension. Terazosin dosage: .

4819790-9 | Hypotension
Patient was taking Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: hypotension on Nov 02, 2005 from UNITED STATES Additional patient health information: Male patient , 81 years of age, weighting 174.6 lb, . Terazosin dosage: .

4819740-5 | Hypotension
Adverse event was reported on Nov 02, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: UNITED STATES , 81 years of age, weighting 151.9 lb, Patient experienced the following unwanted or unexpected effects: hypotension.

4817665-2 | Blood Pressure Orthostatic Abnormal, Dizziness, Syncope
on Nov 01, 2005 Male patient from UNITED STATES , 66 years of age, weighting 164.9 lb, was diagnosed with benign prostatic hyperplasia and was treated with Terazosin (View Usage). Patient had the following side effects: blood pressure orthostatic abnormal, dizziness (What is dizziness?), syncope. Terazosin dosage: 10mg. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), HYDROCODONE 5/ACETAMINOPHEN (View Hydrocodone 5/acetaminophen Review and Hydrocodone 5/acetaminophen Label ), CAPSAICIN (View Capsaicin Review and Capsaicin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

4816902-8 | Orthostatic Hypotension
on Oct 31, 2005 Male patient from UNITED STATES , 61 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: orthostatic hypotension. Terazosin dosage: 5 Mg Qhs. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

4816870-9 | Syncope
Patient was taking Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: syncope on Oct 31, 2005 from UNITED STATES Additional patient health information: Male patient , 86 years of age, was diagnosed with benign prostatic hyperplasia and. Terazosin dosage: 5 Mg Qhs. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4810504-5 | Hypotension
Adverse event was reported on Oct 25, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: UNITED STATES , 81 years of age, weighting 155.0 lb, Patient had the following side effects: hypotension. During the same period patient was treated with DICLOXACILLIN (View Dicloxacillin Review and Dicloxacillin Label ), HALOPERIDOL (View Haloperidol Review and Haloperidol Label ), DOCUSATE/SENNOSIDES (View Docusate/sennosides Review and Docusate/sennosides Label ), RISPERIDONE MICROSPHERE (View Risperidone Microsphere Review and Risperidone Microsphere Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), ACETAMINOPHEN AND HYDROCODONE BITARTRATE (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ).

4734912-6 | Hypotension
on Aug 03, 2005 Male patient from UNITED STATES , 86 years of age, weighting 168.0 lb, was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: hypotension. Terazosin dosage: .

4734414-7 | Hypotension
on Aug 03, 2005 Male patient from UNITED STATES , 80 years of age, weighting 188.1 lb, was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Terazosin dosage: .

4734413-5 | Hypotension
Patient was taking Terazosin (View Usage). Patient had the following side effects: hypotension on Aug 03, 2005 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 206.4 lb, . Terazosin dosage: .

4734251-3 | Hypotension
Adverse event was reported on Aug 03, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: UNITED STATES , 84 years of age, weighting 119.7 lb, After Terazosin was administered, patient had the following side effects: hypotension.

4733338-9 | Syncope
on Aug 01, 2005 Male patient from UNITED STATES , 52 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: syncope. Terazosin dosage: 5 Mg Qhs. During the same period patient was treated with VENLAFAXINE (View Venlafaxine Review and Venlafaxine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), VIAGRA (View Viagra Review and Viagra Label ), LORATADINE (View Loratadine Review and Loratadine Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ). Patient was hospitalized.

4731370-2 | Hypotension
on Aug 01, 2005 Male patient from UNITED STATES , 80 years of age, weighting 203.0 lb, was treated with Terazosin (View Usage). Patient had the following side effects: hypotension. Terazosin dosage: . Patient was hospitalized.

4727194-2 | Bradycardia, Dizziness, Hypotension
Patient was taking Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: bradycardia, dizziness (What is dizziness?), hypotension on Jul 26, 2005 from UNITED STATES Additional patient health information: Male patient , 79 years of age, weighting 203.5 lb, . Terazosin dosage: . During the same period patient was treated with NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

4727186-3 | Hypotension
Adverse event was reported on Jul 26, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: UNITED STATES , 63 years of age, weighting 204.6 lb, Patient experienced the following unwanted or unexpected effects: hypotension. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), OXYCODONE 5MG/ACETAMINOPHEN (View Oxycodone 5mg/acetaminophen Review and Oxycodone 5mg/acetaminophen Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ).

4727165-6 | Hypotension
on Jul 26, 2005 Male patient from UNITED STATES , 76 years of age, weighting 228.0 lb, was treated with Terazosin (View Usage). Patient had the following side effects: hypotension. Terazosin dosage: . During the same period patient was treated with FINASTERIDE (View Finasteride Review and Finasteride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), FERROUS S04 (View Ferrous S04 Review and Ferrous S04 Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

4727162-0 | Dizziness
on Jul 26, 2005 Male patient from UNITED STATES , 84 years of age, weighting 238.1 lb, was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: dizziness (What is dizziness?). Terazosin dosage: . During the same period patient was treated with BETAMETHASONE DIPROPIONATE (View Betamethasone Dipropionate Review and Betamethasone Dipropionate Label ), FLUNISOLIDE (View Flunisolide Review and Flunisolide Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ).

4727051-1 | Hypotension
Patient was taking Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension on Jul 26, 2005 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 145.1 lb, . Terazosin dosage: . During the same period patient was treated with FLUNISOLIDE (View Flunisolide Review and Flunisolide Label ), FORMOTEROL FUMARATE (View Formoterol Fumarate Review and Formoterol Fumarate Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ).

4727047-X | Syncope
Adverse event was reported on Jul 26, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: UNITED STATES , 71 years of age, weighting 185.0 lb, Patient had the following side effects: syncope. During the same period patient was treated with QUINIDINE GLUCONATE (View Quinidine Gluconate Review and Quinidine Gluconate Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), PSYLLIUM (View Psyllium Review and Psyllium Label ).

4727045-6 | Dizziness
on Jul 26, 2005 Male patient from UNITED STATES , 93 years of age, weighting 146.8 lb, was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: dizziness (What is dizziness?). Terazosin dosage: . During the same period patient was treated with CITALOPRAM (View Citalopram Review and Citalopram Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), SENNA (View Senna Review and Senna Label ), LORATADINE (View Loratadine Review and Loratadine Label ), MILK OF MAGNESIA (View Milk Of Magnesia Review and Milk Of Magnesia Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

4718243-6 | Blood Pressure Diastolic Decreased, Dizziness
on Jul 18, 2005 Male patient from UNITED STATES , 75 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure diastolic decreased, dizziness (What is dizziness?). Terazosin dosage: 10mg Po Qhs. During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ALBUTEROL S04 (View Albuterol S04 Review and Albuterol S04 Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

4718156-X | Blood Creatine Increased, Hyperkalaemia
Patient was taking Terazosin (View Usage). Patient had the following side effects: blood creatine increased, hyperkalaemia on Jul 18, 2005 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with benign prostatic hyperplasia, trigeminal neuralgia (What is trigeminal neuralgia?) and. Terazosin dosage: 2 Mg Po Qhs. During the same period patient was treated with GABAPENTIN (600 Mg Po Tid) (View Gabapentin Review and Gabapentin Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PHENAZOPYRIDINE HCL TAB (View Phenazopyridine Hcl Tab Review and Phenazopyridine Hcl Tab Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), FLUNISOLIDE NASAL SPRAY (View Flunisolide Nasal Spray Review and Flunisolide Nasal Spray Label ). Patient was hospitalized.

4697728-5 | Dizziness
Adverse event was reported on Jun 21, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: , 73 years of age, weighting 157.0 lb, After Terazosin was administered, patient had the following side effects: dizziness (What is dizziness?). During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

4695651-3 | Dizziness
on Jun 17, 2005 Male patient from , 66 years of age, weighting 270.1 lb, was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?). Terazosin dosage: . During the same period patient was treated with CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

4695648-3 | Hypotension
on Jun 17, 2005 Male patient from , 51 years of age, weighting 103.0 lb, was treated with Terazosin (View Usage). Patient had the following side effects: hypotension. Terazosin dosage: . During the same period patient was treated with PHENOBARITAL (View Phenobarital Review and Phenobarital Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ).

4695647-1 | Hypotension
Patient was taking Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: hypotension on Jun 17, 2005 from Additional patient health information: Male patient , 79 years of age, weighting 157.9 lb, . Terazosin dosage: . During the same period patient was treated with SODIUM FLUORIDE (View Sodium Fluoride Review and Sodium Fluoride Label ), ROPINIROLE (View Ropinirole Review and Ropinirole Label ), FINASTERIDE (View Finasteride Review and Finasteride Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CLORIMAZOLE (View Clorimazole Review and Clorimazole Label ), GALANTAMINE HYDROBROMIDE (View Galantamine Hydrobromide Review and Galantamine Hydrobromide Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

4695435-6 | Dizziness
Adverse event was reported on Jun 17, 2005 by a Male patient taking Terazosin (View Usage) (Dosage: ) . Location: , 77 years of age, weighting 184.5 lb, Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?). During the same period patient was treated with BETAMETHASONE DIPROPIONATE (View Betamethasone Dipropionate Review and Betamethasone Dipropionate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), HCTZ 50/TRIAMTERENE (View Hctz 50/triamterene Review and Hctz 50/triamterene Label ).

4684930-1 | Fatigue, Syncope
on Jun 06, 2005 Male patient from , weighting 176.0 lb, was diagnosed with prostatic disorder, blood pressure (What is blood pressure?), cardiac disorder and was treated with Terazosin (View Usage). Patient had the following side effects: fatigue, syncope. Terazosin dosage: 10 Mg 1 Cap Hs. During the same period patient was treated with METOPROLOL (100 Mg 1 Tab Bid) (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

4673233-7 | Dizziness
on May 23, 2005 Male patient from , 80 years of age, weighting 252.0 lb, was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: dizziness (What is dizziness?). Terazosin dosage: . During the same period patient was treated with HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CLONIDINE HCL (View Clonidine Hcl Review and Clonidine Hcl Label ), LANOXIN (View Lanoxin Review and Lanoxin Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

4673211-8 | Dizziness
Patient was taking Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?) on May 23, 2005 from Additional patient health information: Male patient , 73 years of age, weighting 123.9 lb, . Terazosin dosage: . During the same period patient was treated with GABAPENTIN (View Gabapentin Review and Gabapentin Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ).

4673189-7 | Hypotension
Adverse event was reported on May 23, 2005 by a Female patient taking Terazosin (View Usage) (Dosage: ) . Location: , 86 years of age, weighting 224.0 lb, Patient had the following side effects: hypotension. During the same period patient was treated with LOVASTATIN (View Lovastatin Review and Lovastatin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), HCTZ 25/TRIAMTERENE (View Hctz 25/triamterene Review and Hctz 25/triamterene Label ), SELEGILINE HCL (View Selegiline Hcl Review and Selegiline Hcl Label ), CARBIDOPA 25/LEVODOPA (View Carbidopa 25/levodopa Review and Carbidopa 25/levodopa Label ).

4673170-8 | Dizziness
on May 23, 2005 Male patient from , 77 years of age, weighting 158.1 lb, was treated with Terazosin (View Usage). After Terazosin was administered, patient had the following side effects: dizziness (What is dizziness?). Terazosin dosage: .

4664900-X | Hypotension
on May 17, 2005 Male patient from , 78 years of age, weighting 123.5 lb, was treated with Terazosin (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension. Terazosin dosage: .

4664198-2 | Blood Pressure Orthostatic Decreased, Dizziness, Heart Rate Increased
Patient was taking Terazosin (View Usage). Patient had the following side effects: blood pressure orthostatic decreased, dizziness (What is dizziness?), heart rate increased on May 16, 2005 from Additional patient health information: Male patient , 70 years of age, weighting 186.3 lb, was diagnosed with hypertension, benign prostatic hyperplasia, atrial fibrillation (What is atrial fibrillation?) and. Terazosin dosage: 2 Mg Po Qhs. During the same period patient was treated with LISINOPRIL (10 Mg Po Daily) (View Lisinopril Review and Lisinopril Label ), SOTALOL (80 Mg Po) (View Sotalol Review and Sotalol Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), LORATADINE (View Loratadine Review and Loratadine Label ), PIROXICAM (View Piroxicam Review and Piroxicam Label ). Patient was hospitalized.